Increased surface CXCR4 expression on circulating B and T cells was previously associated with increased disease severity in SLE (61) and 4/5 patients in our IIM cohort with this endotype were enrolled in the inpatient setting. The gene discussed is CXCR4; the disease is systemic lupus erythematosus.